{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T03:27:08Z","timestamp":1648870028338},"reference-count":38,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018]]},"DOI":"10.1248\/bpb.b17-00304","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T22:23:17Z","timestamp":1519856597000},"page":"312-318","source":"Crossref","is-referenced-by-count":0,"title":["Method for Prediction of Efficacy of Sugammadex Administered to Recover from Rocuronium-Induced Neuromuscular Blockade in Gynecological Laparoscopic Surgery Cases"],"prefix":"10.1248","volume":"41","author":[{"given":"Koji","family":"Kimura","sequence":"first","affiliation":[{"name":"Department of Clinical Evaluation of Drug Efficacy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Omura","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Saiseikai Yokohamashi Tobu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Saiseikai Yokohamashi Tobu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Saiseikai Yokohamashi Tobu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Imaura","sequence":"additional","affiliation":[{"name":"Department of Clinical Evaluation of Drug Efficacy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences"},{"name":"Department of Pharmacy, Saiseikai Yokohamashi Tobu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Clinical Evaluation of Drug Efficacy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Cho YH, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Laparoscopic management of early uterine cancer: 10-year experience in Asan Medical Center. <i>Gynecol. Oncol.<\/i>, <b>106<\/b>, 585\u2013590 (2007)."},{"key":"2","unstructured":"2) Kalogiannidis I, Lambrechts S, Amant F, Neven P, Van Gorp T, Vergote I. Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome. <i>Am. J. Obstet. Gynecol.<\/i>, <b>196<\/b>, 248.e1\u2013248.e8 (2007)."},{"key":"3","unstructured":"3) Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, Spiegel G, Barakat R, Pearl ML, Sharma SK. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. <i>J. Clin. Oncol.<\/i>, <b>27<\/b>, 5331\u20135336 (2009)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Blobner M, Frick CG, Stauble RB, Feussner H, Schaller SJ, Unterbuchner C, Lingg C, Geisler M, Fink H. Neuromuscular blockade improves surgical conditions (NISCO). <i>Surg. Endosc.<\/i>, <b>29<\/b>, 627\u2013636 (2015).","DOI":"10.1007\/s00464-014-3711-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Khuenl-Brady KS, Sparr H. Clinical pharmacokinetics of rocuronium bromide. <i>Clin. Pharmacokinet.<\/i>, <b>31<\/b>, 174\u2013183 (1996).","DOI":"10.2165\/00003088-199631030-00002"},{"key":"6","unstructured":"6) Sparr HJ, Beaufort TM, Fuchs-Buder T. Newer neuromuscular blocking agents: how do they compare with established agents? <i>Drugs<\/i>, <b>61<\/b>, 919\u2013942 (2001)."},{"key":"7","unstructured":"7) Bartkowski RR, Witkowski TA, Azad S, Lessin J, Marr A. Rocuronium onset of action: a comparison with atracurium and vecuronium. <i>Anesth. Analg.<\/i>, <b>77<\/b>, 574\u2013578 (1993)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Foldes FF, Nagashima H, Nguyen HD, Schiller WS, Mason MM, Ohta Y. The neuromuscular effects of ORG9426 in patients receiving balanced anesthesia. <i>Anesthesiology<\/i>, <b>75<\/b>, 191\u2013196 (1991).","DOI":"10.1097\/00000542-199108000-00004"},{"key":"9","unstructured":"9) Lin PL, Liu CC, Fan SZ, Chao A, Shin SC, Tai YT. Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium. <i>Acta Anaesthesiol. Sin.<\/i>, <b>35<\/b>, 127\u2013131 (1997)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. <i>Anesthesiology<\/i>, <b>79<\/b>, 913\u2013918 (1993).","DOI":"10.1097\/00000542-199311000-00007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nava-Ocampo AA, Velazquez-Armenta Y, Moyao-Garcia D, Salmeron J. <i>meta<\/i>-Analysis of the differences in the time to onset of action between rocuronium and vecuronium. <i>Clin. Exp. Pharmacol. Physiol.<\/i>, <b>33<\/b>, 125\u2013130 (2006).","DOI":"10.1111\/j.1440-1681.2006.04338.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Parasa M, Vemuri NN, Shaik MS. Comparison of equipotent doses of rocuronium and vecuronium. <i>Anesthesia, Essays and Researches<\/i>, <b>9<\/b>, 88\u201391 (2015).","DOI":"10.4103\/0259-1162.150676"},{"key":"13","unstructured":"13) Shingu K, Masuzawa M, Omote K, Namiki A, Kikuchi H, Kawamada M, Sato S, Kimura T, Hatano N, Nakatsuka H, Morita K, Hara T, Kanmura Y, Takeda J. Neuromuscular blocking effects of Org 9426 (rocuronium bromide); a comparative study with vecuronium bromide in Japanese patients. <i>Masui. The Japanese Journal of Anesthesiology<\/i>, <b>55<\/b>, 1140\u20131148 (2006)."},{"key":"14","unstructured":"14) van den Broek L, Hommes FD, Nap HJ, Wierda JM. Rocuronium- and mivacurium-induced neuromuscular block and intubating conditions: a comparison with vecuronium. <i>Eur. J. Anaesthesiol. Suppl.<\/i>, <b>11<\/b>, 27\u201330 (1995)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. <i>Anesthesiology<\/i>, <b>98<\/b>, 1042\u20131048 (2003).","DOI":"10.1097\/00000542-200305000-00004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Abrishami A, Ho J, Wong J, Yin L, Chung F. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. <i>Cochrane Database Syst. Rev.<\/i>, <b>2009<\/b>, CD007362 (2009).","DOI":"10.1002\/14651858.CD007362.pub2"},{"key":"17","unstructured":"17) Baldo BA, McDonnell NJ, Pham NH. Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy. <i>Clin. Exp. Allergy<\/i>, <b>41<\/b>, 1663\u20131678 (2011)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, Nakatsuka I, Takeda J. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. <i>Anesth. Analg.<\/i>, <b>117<\/b>, 345\u2013351 (2013).","DOI":"10.1213\/ANE.0b013e3182999672"},{"key":"19","unstructured":"19) Ledowski T, Hillyard S, O\u2019Dea B, Archer R, Vilas-Boas F, Kyle B. Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome. <i>Indian Journal of Anaesthesia<\/i>, <b>57<\/b>, 46\u201351 (2013)."},{"key":"20","unstructured":"20) Ledowski T, Ong JS, Flett T. Neuromuscular monitoring, muscle relaxant use, and reversal at a tertiary teaching hospital 2.5 years after introduction of sugammadex: changes in opinions and clinical practice. <i>Anesthesiol. Res. Pract.<\/i>, <b>2015<\/b>, 367937 (2015)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Errando-Oyonarte CL, Moreno-Sanz C, Vila-Caral P, Ruiz de Adana-Belbel JC, Vazquez-Alonso E, Ramirez-Rodriguez JM, Veiga-Ruiz G, Guasch-Arevalo E, Lora-Tamayo D\u2019Ocon JI. Recommendations on the use of deep neuromuscular blockade by anaesthesiologists and surgeons. AQUILES (Anestesia QUIrurgica para Lograr Eficiencia y Seguridad) Consensus. <i>Rev. Esp. Anestesiol. Reanim.<\/i>, <b>64<\/b>, 95\u2013104 (2017).","DOI":"10.1016\/j.redare.2016.12.001"},{"key":"22","unstructured":"22) Checketts MR, Alladi R, Ferguson K, Gemmell L, Handy JM, Klein AA, Love NJ, Misra U, Morris C, Nathanson MH, Rodney GE, Verma R, Pandit JJ, Association of Anaesthetists of Great Britain and Ireland. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland. <i>Anaesthesia<\/i>, <b>71<\/b>, 85\u201393 (2016)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Lien CA, Kopman AF. Current recommendations for monitoring depth of neuromuscular blockade. <i>Curr. Opin. Anaesthesiol.<\/i>, <b>27<\/b>, 616\u2013622 (2014).","DOI":"10.1097\/ACO.0000000000000132"},{"key":"24","unstructured":"24) Di Marco P, Della Rocca G, Iannuccelli F, Pompei L, Reale C, Pietropaoli P. Knowledge of residual curarization: an Italian survey. <i>Acta Anaesthesiol. Scand.<\/i>, <b>54<\/b>, 307\u2013312 (2010)."},{"key":"25","unstructured":"25) Futter M, Gin T. Neuromuscular block: views from the Western pacific. <i>Anesth. Analg.<\/i>, <b>111<\/b>, 11\u201312 (2010)."},{"key":"26","unstructured":"26) Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. <i>Anaesthesia<\/i>, <b>62<\/b>, 806\u2013809 (2007)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. <i>Anesth. Analg.<\/i>, <b>111<\/b>, 110\u2013119 (2010).","DOI":"10.1213\/ANE.0b013e3181c07428"},{"key":"28","unstructured":"28) Pharmaceuticals and Medical Devices Agency. \u201cNew drug application of BRIDION [in Japanese].\u201d: \u2039http:\/\/www.pmda.go.jp\/drugs\/2010\/P201000004\/index.html\u203a, cited 12 April, 2017."},{"key":"29","unstructured":"29) Pharmaceuticals and Medical Devices Agency. \u201cNew drug application of ESLAX [in Japanese].\u201d: \u2039http:\/\/www.pmda.go.jp\/drugs\/2007\/P200700034\/index.html\u203a, cited 12 April, 2017."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Szenohradszky J, Fisher DM, Segredo V, Caldwell JE, Bragg P, Sharma ML, Gruenke LD, Miller RD. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. <i>Anesthesiology<\/i>, <b>77<\/b>, 899\u2013904 (1992).","DOI":"10.1097\/00000542-199211000-00010"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. <i>Bone Marrow Transplant.<\/i>, <b>48<\/b>, 452\u2013458 (2013).","DOI":"10.1038\/bmt.2012.244"},{"key":"32","unstructured":"32) Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. <i>Behav. Res. Methods<\/i>, <b>39<\/b>, 175\u2013191 (2007)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Staals LM, Snoeck MM, Driessen JJ, Flockton EA, Heeringa M, Hunter JM. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. <i>Br. J. Anaesth.<\/i>, <b>101<\/b>, 492\u2013497 (2008).","DOI":"10.1093\/bja\/aen216"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Cammu G, Van Vlem B, van den Heuvel M, Stet L, el Galta R, Eloot S, Demeyer I. Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment. <i>Br. J. Anaesth.<\/i>, <b>109<\/b>, 382\u2013390 (2012).","DOI":"10.1093\/bja\/aes207"},{"key":"35","unstructured":"35) Staals LM, Snoeck MM, Driessen JJ, van Hamersvelt HW, Flockton EA, van den Heuvel MW, Hunter JM. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. <i>Br. J. Anaesth.<\/i>, <b>104<\/b>, 31\u201339 (2010)."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) McDonagh DL, Benedict PE, Kovac AL, Drover DR, Brister NW, Morte JB, Monk TG. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients. <i>Anesthesiology<\/i>, <b>114<\/b>, 318\u2013329 (2011).","DOI":"10.1097\/ALN.0b013e3182065c36"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Dahl V, Pendeville PE, Hollmann MW, Heier T, Abels EA, Blobner M. Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery. <i>Eur. J. Anaesthesiol.<\/i>, <b>26<\/b>, 874\u2013884 (2009).","DOI":"10.1097\/EJA.0b013e32832c605b"},{"key":"38","unstructured":"38) Pharmaceuticals and Medical Devices Agency. \u201cPackage insert of BRIDION [in Japanese].\u201d: \u2039http:\/\/www.info.pmda.go.jp\/downfiles\/ph\/PDF\/170050_3929409A1023_1_11.pdf\u203a, cited 12 April, 2017."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/3\/41_b17-00304\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T02:08:42Z","timestamp":1570846122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/3\/41_b17-00304\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b17-00304","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}